Diabetes decisions — 2022

The Veteran's claims for ischemic heart disease, diabetes mellitus type II, Parkinson's disease, and PTSD have all been denied as there is no evidence of in-service exposure to herbicides or other factors that would support service connection.,There was no credible supporting evidence found to corroborate the Veteran's claimed service in Vietnam, including his alleged combat service and destruction of an orphanage.

The Veteran's claims for diabetes mellitus, cardioembolic stroke, chronic kidney disease, and chronic lymphocytic leukemia were denied. Service connection was granted with effective date of November 30, 2017, for diabetic polyneuropathy involving the sciatic nerve in both lower extremities.

The Veteran's service connection claims for ischemic heart disease and type II diabetes mellitus are granted due to exposure to Agent Orange in Thailand.

The Board has found the VA's decision to deny PCAFC benefits was inadequate and remanded for an updated medical review. The case is now back with the AOJ for further action.

The Board denied the Veteran's claims for service connection for hypertension, diabetes mellitus, and peripheral vascular disease as there was no evidence of these conditions during or within one year after his military service. The Board also found that exposure to herbicides (Agent Orange) did not occur in Korea, thus denying presumptive service connection based on such exposure.

The Board has remanded the claims for higher ratings and entitlement to TDIU due to incomplete development of records, including VA treatment records. The Veteran's service-connected disabilities are being evaluated by a qualified medical examiner to determine their combined effects on his ability to work.

The Veteran's service connection claims for diabetes mellitus type II and prostate cancer are granted due to presumed exposure to herbicide agents during his service in Thailand, as provided by the PACT Act.

The Veteran's cause of death, coronary artery disease and diabetes mellitus type II, are presumed service-connected due to exposure during his service in Thailand under the PACT Act.

The Veteran's service-connected disabilities did not prevent him from securing or following a substantial gainful occupation prior to December 24, 2014.

The Veteran's DMII with erectile dysfunction is granted a 40 percent disability rating prior to January 21, 2020 and denied for any higher ratings from that date forward.

The Veteran's claim for service connection for diabetes mellitus, type II, due to exposure to chemicals and/or herbicides has been remanded due to lack of substantial compliance with the March 2020 Board remand. The Veteran asserts he was exposed to contaminants including Agent Orange during his active duty service in Guam.

The Board has remanded the Veteran's claims for diabetes mellitus type II, coronary arteriosclerosis, erectile dysfunction (E.D.), bilateral hearing loss, and tinnitus due to incomplete development regarding herbicide exposure in Korea.

Service connection for type 2 diabetes is granted as the Veteran served near the DMZ in Korea and was exposed to herbicide agents, presumptively related to his condition.,Service connection for lichen simplex chronicus and vitiligo is denied as there is no evidence of a nexus between these conditions and service.

The Board has remanded several issues including service connection for various conditions and the effective date of a right lower extremity radiculopathy award. The Veteran's claims for peripheral neuropathy, hypertension, diabetes mellitus, renal cell carcinoma, and a skin disability are also remanded due to potential herbicide exposure in Korea.

The Board has decided to remand the Veteran's claim for service connection for sleep apnea due to insufficient evidence and a need for further development. The examiner is requested to consider obesity as an intermediate step in determining if the Veteran's sleep apnea is secondary to his diabetes mellitus or other service-connected conditions.

The Veteran's death was not caused by any service-connected disability.,VA treatment or medical care did not cause the Veteran's death.

The Board denied service connection for diabetes mellitus type II and remanded the issues of initial rating for mixed anxiety depressive disorder and TDIU.

The Veteran's combined service-connected disabilities have rendered him unable to secure and follow a substantially gainful occupation consistent with his work and education background, thus meeting the criteria for TDIU.

The Board has granted service connection for ischemic heart disease and diabetes mellitus, type II due to herbicide exposure. The claim for hypertension secondary to these conditions is remanded.

The Board has remanded the claims for diabetes mellitus, type II and coronary artery disease due to a lack of substantial compliance with prior remand directives. The AOJ is instructed to verify the Veteran's exposure to herbicides in service, specifically in Okinawa between August 1965 and July 1966, and on Guam or American Samoa during his assignments with the Fleet Marine Force.